Novel test supports vaccine development studies critical to aiding researchers in understanding immunity levels and disease progression.

EUROIMMUN today announced the launch of the CE marked SARS-CoV-2 Antigen ELISA for specific determination of the SARS-CoV-2 protein.

A new method for the treatment of rheumatoid arthritis using neuroplasticity-altering electrical fields is being developed by scientists, to regulate immune function.

EKF Diagnostics has introduced one of the first tests to accurately measure levels of COVID-19 neutralizing antibodies in individuals.

Lonza today announced a collaboration with a global biopharma company. They both aim to commercialize antibody-drug conjugates.

NeurodigitX, announced today a new comprehensive platform called Plastic Health.

Avacta Group plc announces significant progress in the development of a highly scalable manufacturing process for a lateral flow SARS-CoV-2 antigen test.

FairJourney Biologics S.A (FJB) and IONTAS Limited (IONTAS) today announced they have signed an agreement to discover antibodies with Pandion Therapeutics (Pandion).

BioVersys has reached a major milestone by entering clinical development with the start of Phase 1 testing of BV100 in healthy volunteers.

Beckman Coulter today announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark.